Heme oxygenase is the rate-limiting enzyme in the catabolism of heme that results in the release of carbon monoxide, iron, and biliverdin. The products of this enzymatic reaction play important biological roles in antioxidant, anti-inflammatory, and cytoprotective functions. HO comprises two isozymes, including the constitutively expressed HO-2 isozyme and the inducible HO-1 isozyme. Inducible HO-1 is expressed as an adaptive response to several stimuli, including heme, metals, and hormones. The induction of HO-1 has been implicated in numerous disease states, such as transplant rejection, hypertension, atherosclerosis, Alzheimer's disease, endotoxic shock, diabetes, inflammation, and neurological disorders.
[1] Abraham, N.G. and Kappas, A. (2008) Pharmacol Rev 60, 79-127.
[2] Otterbein, L.E. et al. (2003) Trends Immunol 24, 449-55.
[3] Cruse, I. and Maines, M.D. (1988) J Biol Chem 263, 3348-3353.
[4] Maines, M.D. (1988) FASEB J 2, 2557-2568.
[5] Schipper, H.M. et al. (2009) Curr Alzheimer Res 6, 424-430.